Autologous Adoptive Cellular Immunotherapy as an Effective Prophylactic Concurrent Treatment in Reducing the Severity and Mortality of COVID-19 Infection in Cancer Patients
Publication
, Journal Article
Li, C; Xu, D; Lu, L; Zhao, H; Zeng, C; Hu, L; Guo, X; Liu, L; Tang, L; Huo, F; Rong, X; Geng, Z; Lin, P; Wang, X; Yan, Y; Hobeika, A ...
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Li, C., Xu, D., Lu, L., Zhao, H., Zeng, C., Hu, L., … Ren, J. (n.d.). Autologous Adoptive Cellular Immunotherapy as an Effective Prophylactic Concurrent Treatment in Reducing the Severity and Mortality of COVID-19 Infection in Cancer Patients.
Li, Congcong, Dazhao Xu, Linyao Lu, Haiyang Zhao, Chuxiong Zeng, Lina Hu, Xianzhi Guo, et al. “Autologous Adoptive Cellular Immunotherapy as an Effective Prophylactic Concurrent Treatment in Reducing the Severity and Mortality of COVID-19 Infection in Cancer Patients,” n.d.
Li C, Xu D, Lu L, Zhao H, Zeng C, Hu L, et al. Autologous Adoptive Cellular Immunotherapy as an Effective Prophylactic Concurrent Treatment in Reducing the Severity and Mortality of COVID-19 Infection in Cancer Patients.
Li C, Xu D, Lu L, Zhao H, Zeng C, Hu L, Guo X, Liu L, Tang L, Huo F, Rong X, Geng Z, Lin P, Wang X, Yan Y, Hobeika A, Morse MA, Lyerly HK, Ren J. Autologous Adoptive Cellular Immunotherapy as an Effective Prophylactic Concurrent Treatment in Reducing the Severity and Mortality of COVID-19 Infection in Cancer Patients.